Download the Report (PDF, 6.2MB)
Total Page:16
File Type:pdf, Size:1020Kb
YEAR IN REVIEW Institute for Molecular Bioscience 2016 Annual Report CONTENTS ABOUT 4 2016 snapshot 6 Message from the Vice-Chancellor and President 8 Message from the Director 10 2016 highlights 12 DISCOVERY 14 Feature: Shining a diagnostic light on rare diseases 16 Feature: Scientists developing new diagnostic techniques in the fight against superbugs 18 Feature: At the centre of it all, could understanding inflammation provide the silver bullet? 19 Feature: The mysterious language of pain and the fight to switch it off 20 Feature: Growing new organs – science fiction or science future? 22 Grants and fellowships 24 2016 award highlights 26 LEARNING 28 Research training 30 Research Higher Degree students 32 2016 RHD conferrals 34 ENGAGEMENT 36 Research commercialisation 38 Community engagement 40 Global collaborations 42 OUR PEOPLE 44 IMB boards and committees 46 Our people 47 Joint appointments and affiliates 50 Science ambassadors 51 SUPPORTING INFORMATION 52 Financial statement 54 Research grants 55 Research facilities 61 Publications 64 GIVING 66 Discoveries inspired by life 66 THANK YOU TO OUR SUPPORTERS 67 2 IMB YEAR IN REVIEW IMB YEAR IN REVIEW 3 ABOUT The University of Queensland’s Our research is framed through MISSION RESEARCH CENTRES STRATEGIC PRIORITIES Institute for Molecular six research centres focusing on superbug infection, pain, heart disease, Our mission is to advance scientific Centre for Inflammation Discovery excellence Bioscience (IMB) is a global inflammation, solar biotechnology and the knowledge and deliver new health and and Disease Research Translational impacts leader in multidisciplinary life industry applications from the best in interplay of genomics and disease. We Centre for Pain Research Learning sciences research. IMB brings also undertake research in cancer, the life sciences research. Centre for Superbug Solutions Leadership and engagement environment and agricultural solutions. together 500 researchers, Centre for Solar Biotechnology VISION Equity and sustainability students and support staff IMB’s combination of genomics, UQ Project Three Billion biostatistical, biological, from across the globe, using Our vision is to be a global leader in the UQ Centre for Cardiac and pharmacological and chemical life sciences research for discovery and application of molecular Vascular Biology disease discovery, application researchers means the Institute can life sciences research. take life science discoveries from the and sustainable futures. genome to drug design and application – for health, disease and for the sustainable solutions for our cities, fuels and foods. With 66 patents and 11 spin- outs to our name, UQ’s IMB is driven to SHARE IN OUR DISCOVERIES using life science research for discovery, Subscribe to our IMB news and event updates invention and application. imb.uq.edu.au/subscribe JOIN OUR SOCIAL COMMUNITIES Twitter.com/IMBatUQ Facebook.com/InstituteforMolecularBioscience Youtube.com/IMBatUQ THE IMPACT OF OUR RESEARCH SPANS THE AREAS OF Agriculture Cancer Solar Diabetes Infection Pain biotechnology and obesity Heart and Inflammation Brain injury Rare and Superbugs cardiovascular and disease complex diseases diseases 4 IMB YEAR IN REVIEW IMB YEAR IN REVIEW 5 2016 SNAPSHOT research centres 5 total research income 4 38 patent families managed Centre for Pain Research $30.1M competitive funding 7 4 agricultural/industrial biotechnology 20.1 30.1 21 Centre for Inflammation and Disease Research $20.1M operating 7 diagnostic/devices Centre for Superbug Solutions $5M philanthropy, commercialisation, 6 6 drug discovery tools UQ Centre for Cardiac and Vascular Biology other income and recoveries 21 therapeutics Centre for Solar Biotechnology UQ Project Three Billion $ world-class research facilities 10M 9 8 active Australian Research Council Linkage Projects $ with industry partners awarded from the 2.3M National Health and Medical Research Council grant awarded 500 from the 60 new partnerships researchers, postgrad students & support staff formed in 2016 Honours, undergraduate, $ occupational trainee and 4.5M coursework masters students hosted at IMB > % awarded 5 to establish the new ACRF 7 from the Cancer Ultrastructure and of IMB's publications include 121 % Australian Research Council Function Facility new patents filed industry collaborations active research higher degree students 100 honours students 364 achieved first class honours publications 4 Thomson Reuters Highly inflammatory disease Cited Researchers 41 research research higher degree secured up to a students graduated $22M over 1000 collaborations in global investment 40 Host of one of the largest biotech 7 Series A investments for high-impact scientific Fellows of the Australian the Queensland Emory intellectual property originating 57 publications Academy of Science Drug Discovery Initiative (QEDDI) from an Australian university countries 6 IMB YEAR IN REVIEW IMB YEAR IN REVIEW 7 In 2016 the University advanced by In 2016, their innovation delivered By partnering with them in 2016, 22 places in the Academic Ranking of outcomes of global significance: IMB has: MESSAGE FROM THE World Universities, to rank 55th globally They started work on a new Created an organic insecticide that is and second in Australia. UQ is the only generation of drugs to be grown in protecting cotton crops and saving Australian university to rank in the top VICE-CHANCELLOR AND plants; bees; 20 for life sciences – an impressive achievement. As our largest institute, They identified a treatment target for Uncovered compounds in tarantula the Institute for Molecular Bioscience aggressive forms of breast cancer; venom that are a potential treatment plays a significant role in UQ’s success. They grew beating human heart for sheep parasites, a major cost for tissue from stem cells that will one the international sheep industry; However, research excellence in itself day be used to regenerate the hearts Made clean fuel from green algae; PRESIDENT is insufficient for translating discoveries of patients with heart disease; into meaningful outcomes with Attracted $22 million in global They made a discovery that investment to develop new treatments A clear measure of success in science is the impact that discoveries have on the world and the substantial impact. Such translation also could lead to a new treatment for inflammatory diseases such as lives of its people. The University of Queensland (UQ) has earned an international reputation for requires engagement with exceptional partners in industry, government and for Parkinson’s disease, and has Parkinson’s and asthma; excellence in research, as signified by our performance in international rankings. the community, and with researchers potential applications for nearly 50 Developed environmentally friendly who are connected across disciplines. other disorders; cane toad traps to catch tadpoles They progressed the development of before they can reproduce; and This is why the Institute for Molecular new drugs that target the underlying Developed a model to more Bioscience is multidisciplinary. It brings cause of diabetes; accurately forecast CO2 emissions. together researchers with different They identified four new classes of perspectives and expertise, who share The discoveries made at the Institute compounds that act against drug- one goal: high quality Discovery and and their applications attest to the resistant tuberculosis; Translation. They exchange ideas power of a multi-disciplinary approach across fields and challenge each other They identified interactions between to creating impact in Life Sciences to look at things differently, to ask new immune system pathways that could research. questions, and to create new areas of improve treatment of autoimmune I congratulate Director Professor science. They are working with partners and inflammatory diseases; Brandon Wainwright and the Institute on local problems with global impact, They discovered a protein in spider for Molecular Bioscience team. Their forging research discoveries with broad venom that binds to and inhibits pain curiosity in 2016 made an impressive application to combatting disease and receptors, uncovering a promising contribution to advancing human other global challenges. future treatment for chronic pain; and knowledge, to creating change and to They found a diagnosis for some of solving some of the world’s greatest the many Australians suffering from challenges. unresolved rare diseases. Professor Peter Høj Industry, international collaborators and Vice-Chancellor and President funding bodies alike are recognising the The University of Queensland Institute’s ability to translate discoveries into solutions. 8 IMB YEAR IN REVIEW IMB YEAR IN REVIEW 9 MESSAGE FROM THE DIRECTOR Improving quality of life is Here are some examples: IMB secured funding, through an IMB INNOVATORS MAKING DISCOVERY DRIVES US FORWARD Australian Research Council Linkage AN IMPACT the goal of research at IMB, We created the world’s first molecule Solutions to some of life’s most Infrastructure, Equipment and from discovering new ways to bank, crowdsourcing antibiotic One of the greatest signatures of the complicated problems lie in discovering Facilities grant and an Australian compounds from across the globe, enduring quality of our achievements is the essence of life itself. Disease diagnose and treat disease to Cancer Research Foundation to find new antibiotics to fight drug- our staff and research training students. discovery epitomises the mission of the